Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-820132 in Subjects With Type 2 Diabetes Treated With Metformin Monotherapy.

Trial Profile

Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-820132 in Subjects With Type 2 Diabetes Treated With Metformin Monotherapy.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Mar 2012

At a glance

  • Drugs BMS 820132 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Biomarker
  • Most Recent Events

    • 26 Mar 2012 Actual end date changed from Oct 2011 to Nov 2011 as reported by ClinicalTrials.gov.
    • 29 Feb 2012 Actual patient number changed from 64 to 67 as reported by ClinicalTrials.gov.
    • 29 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top